Elevated C-reactive protein (CRP) and homocysteine have been repeatedly implicated, but their routine clinical useis limited by cost, turnaround time and variability [4, 5].In recent years, composite blood-cell ratios obtainable from a standard complete blood count have emerged as inexpensive, reproducibleinflammation markers in cardiovascular and cerebrovascular disease [6, 7-8]. The gene discussed is CRP; the disease is cerebrovascular disorder.